Epigral Ltd

AI
Epigral Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Epigral Ltd

₹ 935 -0.58%
12 Nov - close price
epigral.com BSE: 543332 NSE: EPIGRAL
About

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals.[1]

Key Points

Product Segments[1]
a. Derivatives & Speciality Chemicals (52% in FY26 vs 25% in FY22):[2] The company is the 6th largest producer of Chloromethanes (CMS) in India, its CMS portfolio includes MDC, Chloroform, and CTC. It is also the 5th largest producer of Hydrogen Peroxide in India. It also produces specialty chemicals like CPVC Resin, CPVC compound, Epichlorohydrin, Chlorotoluenes Value Chain, etc. [3]

Website BSE NSE
  • Market Cap ₹ 4,035 Cr.
  • Current Price ₹ 935
  • High / Low ₹ 1,535 / 806
  • Stock P/E 14.2
  • Book Value ₹ 548
  • Dividend Yield 0.53 %
  • ROCE 15.5 %
  • ROE 16.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Debtor days have increased from 42.4 to 60.2 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
478 472 525 651 626 645 628 607 587 597 736 705 746
370 349 369 475 448 463 454 443 455 494 569 526 610
Operating Profit 108 123 155 176 178 183 173 163 132 103 168 179 136
OPM % 23% 26% 30% 27% 28% 28% 28% 27% 22% 17% 23% 25% 18%
1 2 2 2 6 4 4 9 2 6 -1 5 6
Interest 21 20 14 14 27 -0 12 23 22 11 16 7 11
Depreciation 32 31 30 33 32 33 34 42 42 43 42 43 44
Profit before tax 56 74 113 131 125 154 131 107 70 55 110 134 88
Tax % 32% 34% 32% 34% 35% 33% 34% -50% 26% 28% 26% 25% 26%
38 49 77 86 81 104 87 161 51 39 81 100 65
EPS in Rs 9.14 11.81 18.60 20.67 19.57 24.02 20.14 37.25 11.87 9.07 18.76 23.12 15.09
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
829 1,551 2,188 1,929 2,550 2,527 2,785
567 1,041 1,499 1,448 1,839 1,961 2,199
Operating Profit 261 509 689 481 711 566 586
OPM % 32% 33% 31% 25% 28% 22% 21%
2 4 8 7 16 15 16
Interest 29 44 66 73 53 72 45
Depreciation 74 86 109 124 133 168 172
Profit before tax 161 383 522 291 541 341 385
Tax % 37% 34% 32% 33% 34% 3%
101 253 353 196 358 332 285
EPS in Rs 24.48 60.84 85.03 47.14 82.91 76.95 66.04
Dividend Payout % 0% 0% 6% 11% 7% 6%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 5%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 27%
3 Years: -2%
TTM: -29%
Stock Price CAGR
10 Years: %
5 Years: 3%
3 Years: 0%
1 Year: -39%
Return on Equity
10 Years: %
5 Years: 24%
3 Years: 18%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 42 42 42 42 43 43 43
Reserves 432 684 1,028 1,213 1,861 2,178 2,322
753 993 879 964 593 572 570
222 405 484 576 655 712 650
Total Liabilities 1,449 2,124 2,432 2,794 3,152 3,505 3,585
1,102 1,068 1,804 1,767 2,238 2,117 2,061
CWIP 126 589 158 483 64 451 498
Investments 0 0 21 21 98 23 29
221 467 450 524 752 915 997
Total Assets 1,449 2,124 2,432 2,794 3,152 3,505 3,585

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
229 284 626 398 441 436
-197 -455 -437 -401 -262 -355
-32 195 -200 -8 -164 -94
Net Cash Flow 1 24 -11 -11 15 -14
Free Cash Flow 32 -172 210 -1 254 50
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 99% 68% 106% 93% 78% 90%

Ratios

Consolidated / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 52 60 28 34 33 60
Inventory Days 51 74 69 90 105 89
Days Payable 69 42 36 63 50 66
Cash Conversion Cycle 34 92 61 61 88 83
Working Capital Days -92 -26 -41 -54 26 16
ROCE % 29% 32% 17% 25% 15%

Insights

In beta
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Total Installed Manufacturing Capacity (Chlor-Alkali + Derivatives)
KTPA

Log in to view insights

Please log in to see hidden values.

Login
Wind-Solar Hybrid Power Plant Capacity
MW
Plant Capacity Utilization
%
Revenue Mix - Derivatives & Specialty Chemicals
%
Captive Chlorine Consumption
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
71.38% 71.49% 71.58% 71.58% 68.94% 68.95% 68.83% 68.83% 68.83% 68.83% 68.83% 68.83%
1.17% 1.36% 1.46% 2.10% 3.01% 3.01% 3.06% 2.71% 2.36% 1.54% 1.03% 0.99%
0.05% 0.02% 0.18% 1.17% 4.31% 4.66% 4.78% 4.93% 5.13% 4.90% 5.56% 4.89%
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
27.37% 27.10% 26.75% 25.12% 23.71% 23.34% 23.30% 23.52% 23.67% 24.71% 24.56% 25.27%
No. of Shareholders 92,95988,87085,76183,17681,69780,87879,95178,60577,56277,58376,30576,384

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls